Raynaud's Phenomenon Clinical Trial
Official title:
MXQ-503 Applied To The Hand Vs. Nitroglycerin Ointment 2%, USP, Applied To The Chest: A Pharmacokinetic Comparison In Normal Subjects
The purpose of this clinical study is to compare the pharmacokinetic profiles of a topical cream formulation of 0.9% nitroglycerin, MQX 503, and Nitroglycerin Ointment 2%, USP.
n/a
Allocation: Randomized, Endpoint Classification: Pharmacokinetics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00946738 -
The Effect of Physical Therapy on Raynaud`s Phenomenon Secondary to Systemic Sclerosis
|
N/A | |
| Completed |
NCT02050360 -
"As Required" Oral Sildenafil in Raynaud's Phenomenon
|
Phase 2/Phase 3 | |
| Completed |
NCT01117298 -
A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma
|
Phase 3 | |
| Completed |
NCT02583789 -
Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon
|
Early Phase 1 | |
| Terminated |
NCT01315899 -
Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon
|
Phase 2 | |
| Completed |
NCT03058887 -
The Effects of Exercise in Patients With Systemic Sclerosis
|
N/A | |
| Completed |
NCT00700518 -
Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon
|
Phase 1 | |
| Completed |
NCT02506062 -
A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP)
|
N/A | |
| Recruiting |
NCT01378845 -
Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands
|
N/A |